Apple AI is sending misleading push notifications about sensitive stories like Gisele Pelicot's mass rape trial, Britain's grooming gang scandal and a prison officer filmed having sex with an inmate.Concerns have now been raised with Apple by multiple news organisations over the AI summary feature, which is available on iPhones with Apple Intelligence. The feature "must be revoked", the National Union of Journalists told Sky News, as the "inaccurate news summaries shared to audiences through Apple Intellige ...

Delisting and Appeal - Nature's Miracle Holding Inc received a notice from Nasdaq indicating the delisting of its common stock and warrants due to non-compliance with the minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1) [1] - Trading of the Company's common stock and warrants will be suspended on Nasdaq effective at the open of business on January 15, 2025 [1] - The Company has 15 days to request a review of the decision by the Nasdaq Listing and Hearing Review Council, or the Council may independently review the decision within 45 calendar days [2] - The Company is considering appealing the decision [2] Post-Suspension Trading - Upon suspension on Nasdaq, the Company expects its common stock and warrants to be quoted under the symbols "NMHI" and "NMHW" respectively on the OTC Pink market [3] Company Overview - Nature's Miracle Holding Inc is an agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (CEA) industry globally [4] - The Company has recently expanded into EV and bitcoin businesses, both of which are energy-dependent like CEA [4] Forward-Looking Statements - The press release contains forward-looking statements regarding the Company's future expectations, strategies, and plans, including product development, business growth, and market acceptance [5] - These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially [5][6]

ONTARIO, Calif., Jan. 14, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced that on January 13, 2025, the Company received written notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Nasdaq Hearings Panel has determined to delist the Company's common stock and warrants from Nasdaq due to the Company's failure to comply with minimum shareholder's ...

With a 10% total return over the course of one year, Microsoft (NASDAQ: MSFT ) clearly lags the Magnificent 7 stocks. Rather than expressing unjustified concern about its relative underperformance on the one hand, or speculating on"Business valuation is an art, not a science," claim some. However, in my Bachelor's and Master's studies, I have successfully engaged in the scientific examination of valuation and capital investment. Thanks to a cumulative four-year experience in Consulting and Auditing firms in ...

Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Five9, Inc. ("Five9" or the "Company") (NASDAQ: FIVN) investors of a class action representing investors that bought securities between June 4, 2024, and August 8, 2024, inclusive (the "Class Period"). Five9 investors have until February 3, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by p ...

SAN DIEGO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs’ registration statement issued in connection with BioAge Labs’ initial public offering (“IPO”) held on September 26, 2024, have until March 10, 2025 to seek appointment as lead plaintiff of the BioAge Labs class action lawsuit. Captioned Soto v. BioAge Labs, Inc., No. 25-cv-00196 (N.D. Cal.), th ...

Board of Directors Update - Karen J Wilson appointed to the Board of Directors bringing over three decades of leadership experience in the life sciences sector [1][3] - Steven Mintz departed from the Board of Directors after contributing to the company's transition from private to public [4] POZ Platform Technology - Proprietary POZ technology based on poly(2-oxazoline) polymer enables greater control in drug loading and precision in drug release rate [5] - POZ technology aims to improve pharmacokinetic profiles of drugs with narrow therapeutic windows [5] - Potential applications across a broad range of payloads and indications with ongoing out-licensing and partnership arrangements including a non-exclusive license agreement with Pfizer [6] Company Overview - Clinical-stage biotechnology company developing wholly owned drug product candidates for neurological diseases and other indications [7] - POZ Platform technology has potential to improve efficacy and safety profiles of small molecules RNA-based therapeutics and antibody-based drug conjugates [7] - Headquarters located in Huntsville Alabama on the campus of the HudsonAlpha Institute of Biotechnology [7]

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DMC Global Inc. (NASDAQ: BOOM) between May 3, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 4, 2025 lead plaintiff deadline. SO WHAT: If you purchased DMC Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

Executive Changes at JPMorgan Chase - JPMorgan Chase announced significant executive role changes, raising questions about the potential successor to CEO Jamie Dimon [2][4] - Jennifer Piepszak, co-CEO of the Commercial and Investment Bank, will transition to the role of Chief Operating Officer (COO) after expressing her preference not to be considered for the CEO position [3][4] - Daniel Pinto, the current COO, will step down from his role at the end of June [3] - Doug Petno, co-head of Global Banking, will succeed Piepszak as co-CEO of the Commercial and Investment Bank alongside Troy Rohrbaugh [5] - John Simmons, head of Commercial Banking, will succeed Doug Petno in his current role [5] Market Performance and Earnings - JPMorgan Chase shares rose 1.3% to $247.47 on Tuesday, reflecting a 47% gain over the past 12 months [4] - The executive changes were announced ahead of the bank's fourth-quarter earnings report, scheduled for Wednesday [4][5] Potential CEO Successors - The executive reshuffle has shifted focus to Doug Petno, Troy Rohrbaugh, and Marianne Lake, CEO of Consumer and Community Banking, as potential candidates to succeed Jamie Dimon [5] - Jennifer Piepszak has expressed her preference for a senior operating role, working closely with Dimon and supporting the leadership team, rather than pursuing the CEO position [6]

Board Appointments - Warner Bros Discovery has appointed Anthony Noto and Joey Levin to its board of directors, increasing the board size to 13 members [1] - Anthony Noto joined the board on January 8, while Joey Levin will join on February 1, with both standing for election at the company's annual meeting [1] Executive Backgrounds - Anthony Noto is the CEO of SoFi Technologies and previously held executive roles at Twitter (now X) for four years following its IPO, where he served as lead banker for the transaction as co-head of Global TMT Investment Banking at Goldman Sachs [3] - Noto also served as CFO of the National Football League [3] - Joey Levin has over two decades of experience at IAC, holding roles of increasing seniority across mergers & acquisitions, operations, and business management teams, overseeing growth, acquisitions, and spin-offs including Match Group and Vimeo [4] Strategic Value - WBD CEO David Zaslav stated that both new board members bring valuable insights and expertise, with considerable experience in relevant industries and exceptional track records of driving growth, innovation, and shareholder value [2] - The appointments are expected to support the company's strategic and operational objectives to realize the full potential of Warner Bros Discovery [2]